Clinical trial
ALF-STONE: Alfuzosin in Uretheric Stones
NCT00454402 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00454402 |
|---|---|
| Title | ALF-STONE: Alfuzosin in Uretheric Stones |
| Official title | Alfuzosin in Uretheric Stones |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | Alfuzosin |
| Enrollment | 220 |
| Start date | Aug 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Mar 30, 2007 |
| Last update posted | Sep 24, 2007 |
| Countries | Portugal |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: